Your browser is no longer supported. Please, upgrade your browser.
Settings
ABEO Abeona Therapeutics Inc. daily Stock Chart
ABEO [NASD]
Abeona Therapeutics Inc.
Index- P/E- EPS (ttm)-0.60 Insider Own41.49% Shs Outstand32.79M Perf Week-13.08%
Market Cap490.21M Forward P/E- EPS next Y-0.78 Insider Trans0.00% Shs Float23.57M Perf Month70.86%
Income-23.20M PEG- EPS next Q-0.17 Inst Own38.40% Short Float29.85% Perf Quarter149.17%
Sales0.80M P/S612.76 EPS this Y-21.60% Inst Trans9.92% Short Ratio7.49 Perf Half Y211.46%
Book/sh2.21 P/B6.76 EPS next Y-14.70% ROA-23.90% Target Price20.00 Perf Year133.96%
Cash/sh1.78 P/C8.41 EPS next 5Y- ROE-26.70% 52W Range4.05 - 17.90 Perf YTD208.25%
Dividend- P/FCF- EPS past 5Y43.10% ROI- 52W High-16.48% Beta2.37
Dividend %- Quick Ratio14.00 Sales past 5Y-13.50% Gross Margin- 52W Low269.14% ATR1.25
Employees19 Current Ratio14.00 Sales Q/Q0.00% Oper. Margin- RSI (14)60.25 Volatility7.19% 10.64%
OptionableYes Debt/Eq0.00 EPS Q/Q-0.50% Profit Margin- Rel Volume1.54 Prev Close16.20
ShortableYes LT Debt/Eq0.00 EarningsAug 15 Payout- Avg Volume939.27K Price14.95
Recom1.80 SMA209.02% SMA5041.92% SMA200123.64% Volume1,446,590 Change-7.72%
Sep-15-17Initiated RBC Capital Mkts Outperform $23
Jul-18-17Reiterated Maxim Group Buy $14 → $17
Jun-22-17Resumed Jefferies Buy $22
Jan-06-17Initiated Jefferies Buy
Sep-29-16Reiterated Maxim Group Buy $8 → $14
Dec-16-15Initiated Maxim Group Buy $6
Jul-20-15Initiated MLV & Co Buy $15
Sep-22-17 08:45AM  Abeona Therapeutics Announces Upcoming Conference Participation GlobeNewswire -7.72%
Sep-21-17 02:58PM  4 Sell-Ranked Biotech Stocks with Falling Estimates to Avoid Zacks
Sep-20-17 11:17AM  Here's Why These 3 Biotech Stocks Might Stop Rallying Zacks
Sep-18-17 05:16PM  ETFs with exposure to Abeona Therapeutics, Inc. : September 18, 2017 Capital Cube
02:16PM  RBC Capital's Marc Harris breaks down his best biotech pi... CNBC Videos
08:35AM  Abeona Therapeutics (ABEO) Surges: Stock Moves 22.9% Higher Zacks
Sep-15-17 12:13PM  How Should You Think About Abeona Therapeutics Incs (ABEO) Risks? Simply Wall St. +22.86%
Aug-31-17 05:00PM  ETFs with exposure to Abeona Therapeutics, Inc. : August 31, 2017 Capital Cube
04:01PM  Biotechs On The Move Forbes
Aug-29-17 09:05AM  Abeona Therapeutics Receives FDA Breakthrough Therapy Designation for EB-101 Autologous Cell Therapy in Epidermolysis Bullosa GlobeNewswire +18.42%
Aug-25-17 07:30AM  Corporate News Blog - BioDelivery Sciences CEO Dr. Mark A. Sirgo to Retire at Year-End; Will Continue as Vice Chairman ACCESSWIRE -5.73%
Aug-24-17 11:10AM  Abeona Therapeutics, Inc. :ABEO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube +9.71%
Aug-23-17 10:10PM  Edited Transcript of ABEO earnings conference call or presentation 22-Aug-17 2:00pm GMT Thomson Reuters StreetEvents +11.46%
Aug-17-17 09:15AM  Abeona Therapeutics to Host Gene Therapy R&D Day on October 11, 2017 GlobeNewswire
Aug-16-17 09:39AM  Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A GlobeNewswire
Aug-15-17 11:22PM  Abeona Therapeutics reports 2Q loss Associated Press +9.46%
08:25AM  Abeona Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights GlobeNewswire
Jul-25-17 08:05AM  Abeona Therapeutics Announces Appointment of Juan Ruiz as Chief Medical Officer GlobeNewswire
Jul-21-17 01:44PM  Abeona Therapeutics reports 4Q loss Associated Press
Jul-18-17 08:05AM  Abeona Therapeutics Receives Guidance from FDA to Commence Pivotal Phase 3 for EB-101 Gene Therapy for Patients with Epidermolysis Bullosa GlobeNewswire
Jul-10-17 01:49PM  ETFs with exposure to Abeona Therapeutics, Inc. : July 10, 2017 Capital Cube +10.18%
Jul-07-17 05:25PM  Ahead of this year's MLB All-Star Game, here are 4 home r... CNBC Videos +5.70%
Jul-06-17 08:15AM  Abeona Therapeutics (ABEO) Catches Eye: Stock Jumps 10.6% Zacks +8.22%
Jun-29-17 08:15AM  Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-201 Juvenile Batten Disease Gene Therapy Program GlobeNewswire
Jun-28-17 02:30PM  ETFs with exposure to Abeona Therapeutics, Inc. : June 28, 2017 Capital Cube
Jun-27-17 02:36PM  Rare Diseases: Biotech's High Risk, Highest Reward Sub-Sector Forbes
Jun-23-17 09:21AM  6 Biotech Stocks Jefferies Says Are Undervalued Benzinga +7.14%
Jun-16-17 03:18PM  ETFs with exposure to Abeona Therapeutics, Inc. : June 16, 2017 Capital Cube
Jun-05-17 01:58PM  ETFs with exposure to Abeona Therapeutics, Inc. : June 5, 2017 Capital Cube
Jun-04-17 02:33PM  [$$] Clinical Development News, May 29-June 2 The Wall Street Journal
Jun-02-17 09:46AM  Abeona Therapeutics, Inc. :ABEO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
08:05AM  Abeona Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-30-17 08:05AM  Abeona Therapeutics Receives Rare Pediatric Disease Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa GlobeNewswire
May-25-17 08:05AM  Abeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa GlobeNewswire
May-19-17 08:05AM  Abeona Therapeutics to Present at Multiple Upcoming Conferences GlobeNewswire
May-16-17 08:12AM  Abeona Therapeutics reports 1Q loss Associated Press
08:05AM  Abeona Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Highlights GlobeNewswire
May-12-17 08:05AM  Abeona Therapeutics Announces Top-Line Data for ABO-102 Phase 1/2 MPS IIIA Gene Therapy Trial at ASGCT GlobeNewswire
May-09-17 08:05AM  Abeona Therapeutics Receives Regulatory Approval to Initiate Clinical Trial in Australia with ABO-102 Gene Therapy For Patients with MPS IIIA GlobeNewswire
May-08-17 08:05AM  Abeona Therapeutics Announces Gene Therapy Clinical Trial and Preclinical Program Presentations at ASGCT 20th Annual Meeting GlobeNewswire
May-02-17 08:05AM  Abeona Therapeutics Provides Update on EB-101 Gene Therapy for Severe Form of Epidermolysis Bullosa from the Society for Investigative Dermatology Conference GlobeNewswire
Apr-25-17 03:17PM  ETFs with exposure to Abeona Therapeutics, Inc. : April 25, 2017 Capital Cube
08:05AM  Abeona Therapeutics Announces EB-101 Clinical Update to be Presented at the Society for Investigative Dermatology Annual Meeting GlobeNewswire
Apr-20-17 08:05AM  Abeona to Present At Multiple Upcoming Conferences GlobeNewswire
Apr-10-17 07:35PM  Edited Transcript of ABEO earnings conference call or presentation 10-Apr-17 2:00pm GMT Thomson Reuters StreetEvents
Apr-05-17 04:13PM  ETFs with exposure to Abeona Therapeutics, Inc. : April 5, 2017 Capital Cube
07:43AM  Abeona Announces Rare Disease Gene Therapy Symposium with the New York Academy of Sciences GlobeNewswire
Apr-03-17 09:23AM  Abeona Therapeutics, Inc. :ABEO-US: Earnings Analysis: Q4, 2016 By the Numbers : April 3, 2017 Capital Cube
Mar-31-17 12:47PM  ABEONA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
08:05AM  Abeona Therapeutics Reports Q4 2016 Financial Results and Business Highlights GlobeNewswire
Mar-30-17 04:31PM  ABEONA THERAPEUTICS INC. Files SEC form 10-K, Annual Report
Mar-13-17 08:15AM  Abeona Therapeutics to Present at Multiple Upcoming Investor Conferences GlobeNewswire +8.82%
Mar-08-17 08:15AM  Abeona Therapeutics Receives Orphan Drug Designation in the European Union for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa GlobeNewswire
Mar-07-17 07:45AM  Abeona Therapeutics To Present At The Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Mar-03-17 07:44AM  Abeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in Shanghai GlobeNewswire
Feb-27-17 10:39AM  In Honor of International Rare Disease Day, Abeona Therapeutics (Nasdaq: ABEO) Set to Ring the Nasdaq Stock Market Closing Bell GlobeNewswire +5.71%
Feb-23-17 09:26AM  ABEONA THERAPEUTICS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:44AM  Abeona Therapeutics Announces Dismissal of Securities Class Action Lawsuit GlobeNewswire
07:43AM  Abeona Therapeutics Announces Dismissal of Securities Class Action Lawsuit GlobeNewswire
Feb-21-17 07:50AM  Abeona Therapeutics to Present at the 2017 RBC Capital Markets Global Healthcare Conference and 3rd Annual CRISPR Congress GlobeNewswire -12.50%
07:48AM  Abeona Therapeutics to Present at the 2017 RBC Capital Markets Global Healthcare Conference and 3rd Annual CRISPR Congress GlobeNewswire
Feb-17-17 05:07PM  ABEONA THERAPEUTICS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:31AM  Abeona Therapeutics Provides Update from ABO-102 Phase 1/2 MPS IIIA Clinical Trial at the 13th Annual WORLDSymposium 2017 GlobeNewswire
Feb-16-17 09:00AM  3 Companies Looking to Capitalize on Orphan Designation with Multiple Catalyst
Feb-15-17 08:00AM  Abeona Therapeutics (ABEO) Catches Eye: Stock Jumps 5.8% +7.27%
Feb-10-17 12:38PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
11:01AM  ABEO UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Abeona Therapeutics Inc. and a Lead Plaintiff Deadline of February 14, 2017 PR Newswire
Feb-08-17 04:45PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline - February 14, 2017 GlobeNewswire
Feb-07-17 05:34PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm Accesswire +7.00%
01:44PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Abeona Therapeutics Inc. - ABEO PR Newswire
07:46AM  Abeona Therapeutics Announces Presentations and Posters at the 13th Annual WORLDSymposium(TM) 2017 GlobeNewswire
07:45AM  Abeona Therapeutics Announces Presentations and Posters at the 13th Annual WORLDSymposium 2017 GlobeNewswire
Feb-06-17 12:28PM  [$$] Clinical Development News, Jan. 30-Feb. 3 at The Wall Street Journal
11:33AM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
11:00AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Abeona Therapeutics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 Business Wire
09:35AM  February 14th Deadline in Lawsuit for Investors in Abeona Therapeutics Inc (NASDAQ:ABEO) shares announced by Shareholders Foundation Accesswire
Feb-03-17 05:02PM  ABEONA THERAPEUTICS INC. Files SEC form 8-K, Other Events
01:52PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline - February 14, 2017 Accesswire
Feb-01-17 09:45AM  LD Micro Index Reconstitution as of February 1, 2017 Accesswire
07:44AM  Abeona Therapeutics Enrolls First High Dose Subject in Ongoing Phase 1/2 Gene Therapy Clinical Trial in Sanfilippo Syndrome Type A GlobeNewswire
07:43AM  Abeona Therapeutics Enrolls First High Dose Subject in Ongoing Phase 1/2 Gene Therapy Clinical Trial in Sanfilippo Syndrome Type A GlobeNewswire
Jan-31-17 06:16PM  Galena Sacks CEO Amid Escalating Criminal Probe Into Fentanyl Drug Marketing
02:18PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
12:46PM  ABEO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Abeona Therapeutics Inc. and a Lead Plaintiff Deadline of February 14, 2017 GlobeNewswire
Jan-30-17 02:37PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
01:59PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:29AM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline - February 14, 2017 Accesswire
Jan-27-17 04:18PM  ABEONA THERAPEUTICS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
01:08PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm Business Wire
11:48AM  ABEO INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Abeona Therapeutics Inc. and a Lead Plaintiff Deadline of February 14, 2017 Business Wire
Jan-25-17 11:56AM  IMPORTANT ABEO INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:28AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) and Lead Plaintiff Deadline - February 14, 2017 Accesswire
Jan-24-17 09:03PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm Business Wire
07:57PM  ABEO LOSS NOTICE: Rosen Law Firm Reminds Abeona Therapeutics Inc. Investors of Important Feb. 14 Deadline in Class Action - ABEO GlobeNewswire
12:03PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
10:23AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Abeona Therapeutics Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 ABEO GlobeNewswire
Jan-19-17 02:56PM  EQUITY ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
12:04PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Abeona Therapeutics Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 - ABEO Accesswire
Abeona Therapeutics Inc., a biopharmaceutical company, focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The company offers MuGard, a mucoadhesive oral wound rinse for mucositis, stomatitis, aphthous ulcers, and traumatic ulcers; and ProctiGard, a mucoadhesive oral wound rinse for the treatment of rectal mucositis and radiation proctitis. Its lead program is an adeno-associated virus (AAV)-based gene therapy for sanfilippo syndrome. The company develops ABO-101 for Mucopolysaccharidosis (MPS) III, a sanfilippo syndrome Type B; ABO-102 for MPS III, a sanfilippo syndrome Type A; ABO-201 for juvenile batten disease; ABO-301 for fanconi anemia; and clustered, regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 AAV for rare blood diseases. It also develops PTB-101 salt diafiltration process (SDF) Alpha, a alpha1-proteinase inhibitor for chronic augmentation and maintenance therapy in adults with clinically evident emphysema due to severe deficiency of alpha1-proteinase inhibitor; and PTB-102 SDF IVIG, an intravenous immunoglobulin for autoimmune, infectious, and idiopathic diseases. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1989 and is based in Dallas, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ahn Mark JDirectorNov 08Option Exercise2.31150,000346,500493,182Nov 09 04:56 PM